Edition:
India

Sun Pharma Advanced Research Company Ltd (SPRC.NS)

SPRC.NS on National Stock Exchange of India

388.85INR
25 Jun 2018
Change (% chg)

Rs-8.45 (-2.13%)
Prev Close
Rs397.30
Open
Rs395.00
Day's High
Rs407.00
Day's Low
Rs385.15
Volume
734,393
Avg. Vol
369,162
52-wk High
Rs532.00
52-wk Low
Rs292.15

Latest Key Developments (Source: Significant Developments)

Sun Pharma Advanced Research June-qtr loss widens
Friday, 29 Jul 2016 

Sun Pharma Advanced Research Company Ltd : June-quarter net loss 364.1 million rupees versus loss of 16.5 million rupees last year . June-quarter total income from operations 214.8 million rupees versus 434.4 million rupees last year .  Full Article

Sun Pharma and Almirall signs license deal for Psoriasis treatment
Thursday, 28 Jul 2016 

Sun Pharmaceutical Industries Ltd : Almirall and Sun Pharma enter into a license agreement for Tildrakizumab in Europe for Psoriasis . To receive development & regulatory milestone payments, royalties, the terms of which are confidential .  Full Article

Almirall signs license deal with Sun Pharma for psoriasis treatment
Wednesday, 27 Jul 2016 

Almirall SA : Says enters into a license agreement with Sun Pharma Industries for tildrakizumab in Europe for psoriasis . Says to pay Sun Pharma an initial upfront payment of $50 million . Says Sun Pharma will be eligible to get milestone payments, sales milestone payments and royalties on net sales .Says phase-3 studies of tildrakizumab have recently been completed.  Full Article

BUZZ-India's Sun Pharma hits over 3-mth high after U.S. FDA lifts supply curbs

** Shares of Sun Pharmaceutical Industries gain as much as 3.8 pct to 560.95 rupees - highest since March 6